1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Natural Killer Cell Therapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 NK Cell Therapies 1.2.3 NK Cell Directed Antibodies 1.3 Market by Application 1.3.1 Global Natural Killer Cell Therapy Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Cancer 1.3.3 Gastrointestinal Diseases 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Natural Killer Cell Therapy Market Perspective (2016-2027) 2.2 Natural Killer Cell Therapy Growth Trends by Regions 2.2.1 Natural Killer Cell Therapy Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Natural Killer Cell Therapy Historic Market Share by Regions (2016-2021) 2.2.3 Natural Killer Cell Therapy Forecasted Market Size by Regions (2022-2027) 2.3 Natural Killer Cell Therapy Industry Dynamic 2.3.1 Natural Killer Cell Therapy Market Trends 2.3.2 Natural Killer Cell Therapy Market Drivers 2.3.3 Natural Killer Cell Therapy Market Challenges 2.3.4 Natural Killer Cell Therapy Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Natural Killer Cell Therapy Players by Revenue 3.1.1 Global Top Natural Killer Cell Therapy Players by Revenue (2016-2021) 3.1.2 Global Natural Killer Cell Therapy Revenue Market Share by Players (2016-2021) 3.2 Global Natural Killer Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Natural Killer Cell Therapy Revenue 3.4 Global Natural Killer Cell Therapy Market Concentration Ratio 3.4.1 Global Natural Killer Cell Therapy Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Natural Killer Cell Therapy Revenue in 2020 3.5 Natural Killer Cell Therapy Key Players Head office and Area Served 3.6 Key Players Natural Killer Cell Therapy Product Solution and Service 3.7 Date of Enter into Natural Killer Cell Therapy Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Natural Killer Cell Therapy Breakdown Data by Type 4.1 Global Natural Killer Cell Therapy Historic Market Size by Type (2016-2021) 4.2 Global Natural Killer Cell Therapy Forecasted Market Size by Type (2022-2027) 5 Natural Killer Cell Therapy Breakdown Data by Application 5.1 Global Natural Killer Cell Therapy Historic Market Size by Application (2016-2021) 5.2 Global Natural Killer Cell Therapy Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Natural Killer Cell Therapy Market Size (2016-2027) 6.2 North America Natural Killer Cell Therapy Market Size by Type 6.2.1 North America Natural Killer Cell Therapy Market Size by Type (2016-2021) 6.2.2 North America Natural Killer Cell Therapy Market Size by Type (2022-2027) 6.2.3 North America Natural Killer Cell Therapy Market Size by Type (2016-2027) 6.3 North America Natural Killer Cell Therapy Market Size by Application 6.3.1 North America Natural Killer Cell Therapy Market Size by Application (2016-2021) 6.3.2 North America Natural Killer Cell Therapy Market Size by Application (2022-2027) 6.3.3 North America Natural Killer Cell Therapy Market Size by Application (2016-2027) 6.4 North America Natural Killer Cell Therapy Market Size by Country 6.4.1 North America Natural Killer Cell Therapy Market Size by Country (2016-2021) 6.4.2 North America Natural Killer Cell Therapy Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Natural Killer Cell Therapy Market Size (2016-2027) 7.2 Europe Natural Killer Cell Therapy Market Size by Type 7.2.1 Europe Natural Killer Cell Therapy Market Size by Type (2016-2021) 7.2.2 Europe Natural Killer Cell Therapy Market Size by Type (2022-2027) 7.2.3 Europe Natural Killer Cell Therapy Market Size by Type (2016-2027) 7.3 Europe Natural Killer Cell Therapy Market Size by Application 7.3.1 Europe Natural Killer Cell Therapy Market Size by Application (2016-2021) 7.3.2 Europe Natural Killer Cell Therapy Market Size by Application (2022-2027) 7.3.3 Europe Natural Killer Cell Therapy Market Size by Application (2016-2027) 7.4 Europe Natural Killer Cell Therapy Market Size by Country 7.4.1 Europe Natural Killer Cell Therapy Market Size by Country (2016-2021) 7.4.2 Europe Natural Killer Cell Therapy Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Natural Killer Cell Therapy Market Size (2016-2027) 8.2 Asia-Pacific Natural Killer Cell Therapy Market Size by Type 8.2.1 Asia-Pacific Natural Killer Cell Therapy Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Natural Killer Cell Therapy Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Natural Killer Cell Therapy Market Size by Type (2016-2027) 8.3 Asia-Pacific Natural Killer Cell Therapy Market Size by Application 8.3.1 Asia-Pacific Natural Killer Cell Therapy Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Natural Killer Cell Therapy Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Natural Killer Cell Therapy Market Size by Application (2016-2027) 8.4 Asia-Pacific Natural Killer Cell Therapy Market Size by Region 8.4.1 Asia-Pacific Natural Killer Cell Therapy Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Natural Killer Cell Therapy Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Natural Killer Cell Therapy Market Size (2016-2027) 9.2 Latin America Natural Killer Cell Therapy Market Size by Type 9.2.1 Latin America Natural Killer Cell Therapy Market Size by Type (2016-2021) 9.2.2 Latin America Natural Killer Cell Therapy Market Size by Type (2022-2027) 9.2.3 Latin America Natural Killer Cell Therapy Market Size by Type (2016-2027) 9.3 Latin America Natural Killer Cell Therapy Market Size by Application 9.3.1 Latin America Natural Killer Cell Therapy Market Size by Application (2016-2021) 9.3.2 Latin America Natural Killer Cell Therapy Market Size by Application (2022-2027) 9.3.3 Latin America Natural Killer Cell Therapy Market Size by Application (2016-2027) 9.4 Latin America Natural Killer Cell Therapy Market Size by Country 9.4.1 Latin America Natural Killer Cell Therapy Market Size by Country (2016-2021) 9.4.2 Latin America Natural Killer Cell Therapy Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Natural Killer Cell Therapy Market Size (2016-2027) 10.2 Middle East & Africa Natural Killer Cell Therapy Market Size by Type 10.2.1 Middle East & Africa Natural Killer Cell Therapy Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Natural Killer Cell Therapy Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Natural Killer Cell Therapy Market Size by Type (2016-2027) 10.3 Middle East & Africa Natural Killer Cell Therapy Market Size by Application 10.3.1 Middle East & Africa Natural Killer Cell Therapy Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Natural Killer Cell Therapy Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Natural Killer Cell Therapy Market Size by Application (2016-2027) 10.4 Middle East & Africa Natural Killer Cell Therapy Market Size by Country 10.4.1 Middle East & Africa Natural Killer Cell Therapy Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Natural Killer Cell Therapy Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Nektar Therapeutics 11.1.1 Nektar Therapeutics Company Details 11.1.2 Nektar Therapeutics Business Overview 11.1.3 Nektar Therapeutics Natural Killer Cell Therapy Introduction 11.1.4 Nektar Therapeutics Revenue in Natural Killer Cell Therapy Business (2016-2021) 11.1.5 Nektar Therapeutics Recent Development 11.2 Innate Pharma SA 11.2.1 Innate Pharma SA Company Details 11.2.2 Innate Pharma SA Business Overview 11.2.3 Innate Pharma SA Natural Killer Cell Therapy Introduction 11.2.4 Innate Pharma SA Revenue in Natural Killer Cell Therapy Business (2016-2021) 11.2.5 Innate Pharma SA Recent Development 11.3 Affimed 11.3.1 Affimed Company Details 11.3.2 Affimed Business Overview 11.3.3 Affimed Natural Killer Cell Therapy Introduction 11.3.4 Affimed Revenue in Natural Killer Cell Therapy Business (2016-2021) 11.3.5 Affimed Recent Development 11.4 Chipscreen Biosciences 11.4.1 Chipscreen Biosciences Company Details 11.4.2 Chipscreen Biosciences Business Overview 11.4.3 Chipscreen Biosciences Natural Killer Cell Therapy Introduction 11.4.4 Chipscreen Biosciences Revenue in Natural Killer Cell Therapy Business (2016-2021) 11.4.5 Chipscreen Biosciences Recent Development 11.5 Glycostem Therapeutics 11.5.1 Glycostem Therapeutics Company Details 11.5.2 Glycostem Therapeutics Business Overview 11.5.3 Glycostem Therapeutics Natural Killer Cell Therapy Introduction 11.5.4 Glycostem Therapeutics Revenue in Natural Killer Cell Therapy Business (2016-2021) 11.5.5 Glycostem Therapeutics Recent Development 11.6 Fate Therapeutics 11.6.1 Fate Therapeutics Company Details 11.6.2 Fate Therapeutics Business Overview 11.6.3 Fate Therapeutics Natural Killer Cell Therapy Introduction 11.6.4 Fate Therapeutics Revenue in Natural Killer Cell Therapy Business (2016-2021) 11.6.5 Fate Therapeutics Recent Development 11.7 Dragonfly Therapeutics 11.7.1 Dragonfly Therapeutics Company Details 11.7.2 Dragonfly Therapeutics Business Overview 11.7.3 Dragonfly Therapeutics Natural Killer Cell Therapy Introduction 11.7.4 Dragonfly Therapeutics Revenue in Natural Killer Cell Therapy Business (2016-2021) 11.7.5 Dragonfly Therapeutics Recent Development 11.8 Kiadis Pharma 11.8.1 Kiadis Pharma Company Details 11.8.2 Kiadis Pharma Business Overview 11.8.3 Kiadis Pharma Natural Killer Cell Therapy Introduction 11.8.4 Kiadis Pharma Revenue in Natural Killer Cell Therapy Business (2016-2021) 11.8.5 Kiadis Pharma Recent Development 11.9 Nkarta Therapeutics 11.9.1 Nkarta Therapeutics Company Details 11.9.2 Nkarta Therapeutics Business Overview 11.9.3 Nkarta Therapeutics Natural Killer Cell Therapy Introduction 11.9.4 Nkarta Therapeutics Revenue in Natural Killer Cell Therapy Business (2016-2021) 11.9.5 Nkarta Therapeutics Recent Development 11.10 NantKwest 11.10.1 NantKwest Company Details 11.10.2 NantKwest Business Overview 11.10.3 NantKwest Natural Killer Cell Therapy Introduction 11.10.4 NantKwest Revenue in Natural Killer Cell Therapy Business (2016-2021) 11.10.5 NantKwest Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Natural Killer Cell Therapy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of NK Cell Therapies Table 3. Key Players of NK Cell Directed Antibodies Table 4. Global Natural Killer Cell Therapy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 5. Global Natural Killer Cell Therapy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Natural Killer Cell Therapy Market Size by Regions (2016-2021) & (US$ Million) Table 7. Global Natural Killer Cell Therapy Market Share by Regions (2016-2021) Table 8. Global Natural Killer Cell Therapy Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 9. Global Natural Killer Cell Therapy Market Share by Regions (2022-2027) Table 10. Natural Killer Cell Therapy Market Trends Table 11. Natural Killer Cell Therapy Market Drivers Table 12. Natural Killer Cell Therapy Market Challenges Table 13. Natural Killer Cell Therapy Market Restraints Table 14. Global Natural Killer Cell Therapy Revenue by Players (2016-2021) & (US$ Million) Table 15. Global Natural Killer Cell Therapy Market Share by Players (2016-2021) Table 16. Global Top Natural Killer Cell Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Natural Killer Cell Therapy as of 2020) Table 17. Ranking of Global Top Natural Killer Cell Therapy Companies by Revenue (US$ Million) in 2020 Table 18. Global 5 Largest Players Market Share by Natural Killer Cell Therapy Revenue (CR5 and HHI) & (2016-2021) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Natural Killer Cell Therapy Product Solution and Service Table 21. Date of Enter into Natural Killer Cell Therapy Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Natural Killer Cell Therapy Market Size by Type (2016-2021) (US$ Million) Table 24. Global Natural Killer Cell Therapy Revenue Market Share by Type (2016-2021) Table 25. Global Natural Killer Cell Therapy Forecasted Market Size by Type (2022-2027) (US$ Million) Table 26. Global Natural Killer Cell Therapy Revenue Market Share by Type (2022-2027) & (US$ Million) Table 27. Global Natural Killer Cell Therapy Market Size Share by Application (2016-2021) & (US$ Million) Table 28. Global Natural Killer Cell Therapy Revenue Market Share by Application (2016-2021) Table 29. Global Natural Killer Cell Therapy Forecasted Market Size by Application (2022-2027) (US$ Million) Table 30. Global Natural Killer Cell Therapy Revenue Market Share by Application (2022-2027) & (US$ Million) Table 31. North America Natural Killer Cell Therapy Market Size by Type (2016-2021) (US$ Million) Table 32. North America Natural Killer Cell Therapy Market Size by Type (2022-2027) & (US$ Million) Table 33. North America Natural Killer Cell Therapy Market Size by Application (2016-2021) (US$ Million) Table 34. North America Natural Killer Cell Therapy Market Size by Application (2022-2027) & (US$ Million) Table 35. North America Natural Killer Cell Therapy Market Size by Country (2016-2021) & (US$ Million) Table 36. North America Natural Killer Cell Therapy Market Size by Country (2022-2027) & (US$ Million) Table 37. Europe Natural Killer Cell Therapy Market Size by Type (2016-2021) (US$ Million) Table 38. Europe Natural Killer Cell Therapy Market Size by Type (2022-2027) & (US$ Million) Table 39. Europe Natural Killer Cell Therapy Market Size by Application (2016-2021) (US$ Million) Table 40. Europe Natural Killer Cell Therapy Market Size by Application (2022-2027) & (US$ Million) Table 41. Europe Natural Killer Cell Therapy Market Size by Country (2016-2021) & (US$ Million) Table 42. Europe Natural Killer Cell Therapy Market Size by Country (2022-2027) & (US$ Million) Table 43. Asia-Pacific Natural Killer Cell Therapy Market Size by Type (2016-2021) (US$ Million) Table 44. Asia-Pacific Natural Killer Cell Therapy Market Size by Type (2022-2027) & (US$ Million) Table 45. Asia-Pacific Natural Killer Cell Therapy Market Size by Application (2016-2021) (US$ Million) Table 46. Asia-Pacific Natural Killer Cell Therapy Market Size by Application (2022-2027) & (US$ Million) Table 47. Asia-Pacific Natural Killer Cell Therapy Market Size by Region (2016-2021) & (US$ Million) Table 48. Asia-Pacific Natural Killer Cell Therapy Market Size by Region (2022-2027) & (US$ Million) Table 49. Latin America Natural Killer Cell Therapy Market Size by Type (2016-2021) (US$ Million) Table 50. Latin America Natural Killer Cell Therapy Market Size by Type (2022-2027) & (US$ Million) Table 51. Latin America Natural Killer Cell Therapy Market Size by Application (2016-2021) (US$ Million) Table 52. Latin America Natural Killer Cell Therapy Market Size by Application (2022-2027) & (US$ Million) Table 53. Latin America Natural Killer Cell Therapy Market Size by Country (2016-2021) & (US$ Million) Table 54. Latin America Natural Killer Cell Therapy Market Size by Country (2022-2027) & (US$ Million) Table 55. Middle East & Africa Natural Killer Cell Therapy Market Size by Type (2016-2021) (US$ Million) Table 56. Middle East & Africa Natural Killer Cell Therapy Market Size by Type (2022-2027) & (US$ Million) Table 57. Middle East & Africa Natural Killer Cell Therapy Market Size by Application (2016-2021) (US$ Million) Table 58. Middle East & Africa Natural Killer Cell Therapy Market Size by Application (2022-2027) & (US$ Million) Table 59. Middle East & Africa Natural Killer Cell Therapy Market Size by Country (2016-2021) & (US$ Million) Table 60. Middle East & Africa Natural Killer Cell Therapy Market Size by Country (2022-2027) & (US$ Million) Table 61. Nektar Therapeutics Company Details Table 62. Nektar Therapeutics Business Overview Table 63. Nektar Therapeutics Natural Killer Cell Therapy Product Table 64. Nektar Therapeutics Revenue in Natural Killer Cell Therapy Business (2016-2021) & (US$ Million) Table 65. Nektar Therapeutics Recent Development Table 66. Innate Pharma SA Company Details Table 67. Innate Pharma SA Business Overview Table 68. Innate Pharma SA Natural Killer Cell Therapy Product Table 69. Innate Pharma SA Revenue in Natural Killer Cell Therapy Business (2016-2021) & (US$ Million) Table 70. Innate Pharma SA Recent Development Table 71. Affimed Company Details Table 72. Affimed Business Overview Table 73. Affimed Natural Killer Cell Therapy Product Table 74. Affimed Revenue in Natural Killer Cell Therapy Business (2016-2021) & (US$ Million) Table 75. Affimed Recent Development Table 76. Chipscreen Biosciences Company Details Table 77. Chipscreen Biosciences Business Overview Table 78. Chipscreen Biosciences Natural Killer Cell Therapy Product Table 79. Chipscreen Biosciences Revenue in Natural Killer Cell Therapy Business (2016-2021) & (US$ Million) Table 80. Chipscreen Biosciences Recent Development Table 81. Glycostem Therapeutics Company Details Table 82. Glycostem Therapeutics Business Overview Table 83. Glycostem Therapeutics Natural Killer Cell Therapy Product Table 84. Glycostem Therapeutics Revenue in Natural Killer Cell Therapy Business (2016-2021) & (US$ Million) Table 85. Glycostem Therapeutics Recent Development Table 86. Fate Therapeutics Company Details Table 87. Fate Therapeutics Business Overview Table 88. Fate Therapeutics Natural Killer Cell Therapy Product Table 89. Fate Therapeutics Revenue in Natural Killer Cell Therapy Business (2016-2021) & (US$ Million) Table 90. Fate Therapeutics Recent Development Table 91. Dragonfly Therapeutics Company Details Table 92. Dragonfly Therapeutics Business Overview Table 93. Dragonfly Therapeutics Natural Killer Cell Therapy Product Table 94. Dragonfly Therapeutics Revenue in Natural Killer Cell Therapy Business (2016-2021) & (US$ Million) Table 95. Dragonfly Therapeutics Recent Development Table 96. Kiadis Pharma Company Details Table 97. Kiadis Pharma Business Overview Table 98. Kiadis Pharma Revenue in Natural Killer Cell Therapy Business (2016-2021) & (US$ Million) Table 99. Kiadis Pharma Recent Development Table 100. Nkarta Therapeutics Company Details Table 101. Nkarta Therapeutics Business Overview Table 102. Nkarta Therapeutics Natural Killer Cell Therapy Product Table 103. Nkarta Therapeutics Revenue in Natural Killer Cell Therapy Business (2016-2021) & (US$ Million) Table 104. Nkarta Therapeutics Recent Development Table 105. NantKwest Company Details Table 106. NantKwest Business Overview Table 107. NantKwest Natural Killer Cell Therapy Product Table 108. NantKwest Revenue in Natural Killer Cell Therapy Business (2016-2021) & (US$ Million) Table 109. NantKwest Recent Development Table 110. Research Programs/Design for This Report Table 111. Key Data Information from Secondary Sources Table 112. Key Data Information from Primary Sources List of Figures Figure 1. Global Natural Killer Cell Therapy Market Share by Type: 2020 VS 2027 Figure 2. NK Cell Therapies Features Figure 3. NK Cell Directed Antibodies Features Figure 4. Global Natural Killer Cell Therapy Market Share by Application: 2020 VS 2027 Figure 5. Cancer Case Studies Figure 6. Gastrointestinal Diseases Case Studies Figure 7. Others Case Studies Figure 8. Natural Killer Cell Therapy Report Years Considered Figure 9. Global Natural Killer Cell Therapy Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 10. Global Natural Killer Cell Therapy Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 11. Global Natural Killer Cell Therapy Market Share by Regions: 2020 VS 2027 Figure 12. Global Natural Killer Cell Therapy Market Share by Regions (2022-2027) Figure 13. Global Natural Killer Cell Therapy Market Share by Players in 2020 Figure 14. Global Top Natural Killer Cell Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Natural Killer Cell Therapy as of 2020 Figure 15. The Top 10 and 5 Players Market Share by Natural Killer Cell Therapy Revenue in 2020 Figure 16. Global Natural Killer Cell Therapy Revenue Market Share by Type (2016-2021) Figure 17. Global Natural Killer Cell Therapy Revenue Market Share by Type (2022-2027) Figure 18. North America Natural Killer Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 19. North America Natural Killer Cell Therapy Market Share by Type (2016-2027) Figure 20. North America Natural Killer Cell Therapy Market Share by Application (2016-2027) Figure 21. North America Natural Killer Cell Therapy Market Share by Country (2016-2027) Figure 22. United States Natural Killer Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 23. Canada Natural Killer Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Europe Natural Killer Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe Natural Killer Cell Therapy Market Share by Type (2016-2027) Figure 26. Europe Natural Killer Cell Therapy Market Share by Application (2016-2027) Figure 27. Europe Natural Killer Cell Therapy Market Share by Country (2016-2027) Figure 28. Germany Natural Killer Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. France Natural Killer Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. U.K. Natural Killer Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. Italy Natural Killer Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Russia Natural Killer Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Nordic Natural Killer Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Asia-Pacific Natural Killer Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific Natural Killer Cell Therapy Market Share by Type (2016-2027) Figure 36. Asia-Pacific Natural Killer Cell Therapy Market Share by Application (2016-2027) Figure 37. Asia-Pacific Natural Killer Cell Therapy Market Share by Region (2016-2027) Figure 38. China Natural Killer Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Japan Natural Killer Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. South Korea Natural Killer Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Southeast Asia Natural Killer Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. India Natural Killer Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Australia Natural Killer Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Latin America Natural Killer Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America Natural Killer Cell Therapy Market Share by Type (2016-2027) Figure 46. Latin America Natural Killer Cell Therapy Market Share by Application (2016-2027) Figure 47. Latin America Natural Killer Cell Therapy Market Share by Country (2016-2027) Figure 48. Mexico Natural Killer Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Brazil Natural Killer Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Middle East & Africa Natural Killer Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa Natural Killer Cell Therapy Market Share by Type (2016-2027) Figure 52. Middle East & Africa Natural Killer Cell Therapy Market Share by Application (2016-2027) Figure 53. Middle East & Africa Natural Killer Cell Therapy Market Share by Country (2016-2027) Figure 54. Turkey Natural Killer Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Saudi Arabia Natural Killer Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. UAE Natural Killer Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Nektar Therapeutics Revenue Growth Rate in Natural Killer Cell Therapy Business (2016-2021) Figure 58. Innate Pharma SA Revenue Growth Rate in Natural Killer Cell Therapy Business (2016-2021) Figure 59. Affimed Revenue Growth Rate in Natural Killer Cell Therapy Business (2016-2021) Figure 60. Chipscreen Biosciences Revenue Growth Rate in Natural Killer Cell Therapy Business (2016-2021) Figure 61. Glycostem Therapeutics Revenue Growth Rate in Natural Killer Cell Therapy Business (2016-2021) Figure 62. Fate Therapeutics Revenue Growth Rate in Natural Killer Cell Therapy Business (2016-2021) Figure 63. Dragonfly Therapeutics Revenue Growth Rate in Natural Killer Cell Therapy Business (2016-2021) Figure 64. Kiadis Pharma Revenue Growth Rate in Natural Killer Cell Therapy Business (2016-2021) Figure 65. Nkarta Therapeutics Revenue Growth Rate in Natural Killer Cell Therapy Business (2016-2021) Figure 66. NantKwest Revenue Growth Rate in Natural Killer Cell Therapy Business (2016-2021) Figure 67. Bottom-up and Top-down Approaches for This Report Figure 68. Data Triangulation Figure 69. Key Executives Interviewed

Nektar Therapeutics Innate Pharma SA Affimed Chipscreen Biosciences Glycostem Therapeutics Fate Therapeutics Dragonfly Therapeutics Kiadis Pharma Nkarta Therapeutics NantKwest